Abstract: An object of the present invention is to provide means for treating post-traumatic stress disorder or a blast-induced traumatic brain injury-protective agent. The present invention provides a pharmaceutical composition containing hydrogen as an active ingredient, used for treating post-traumatic stress disorder or protecting against blast-induced traumatic brain injury.

Abstract: The purpose of the present disclosure is to provide a pellicle that has an adhesive layer having good flatness, and a method for producing the pellicle with good reproducibility. Said purpose is achieved by a pellicle having: a pellicle frame; a pellicle film provided so as to be stretched on one end surface of the pellicle frame; and an adhesive layer provided on the other end surface of the pellicle frame. The adhesive layer contains a cured product of a resin composition containing a curable polymer (A), and a curing agent (B1) and a curing agent (B2). The curing agent (B1) and the curing agent (B2) have different curing conditions.

Abstract: Task of the present invention is to provide a tackifier solution having high solution stability and also provide, by using such a tackifier solution, a pellicle having only few tackifier residues and exhibiting reduced outgas generation. Present invention is a pellicle comprising a pellicle frame, a pellicle membrane stretched over an end surface of one opening of the pellicle frame, and a tackifier layer provided on an end surface of the other opening of the pellicle frame, wherein the tackifier layer contains a (meth)acrylic tackifier which is a solidified resin composition comprising a polymer (A) and a radical polymerization initiator (B), the polymer (A) having a structural unit derived from a (meth)acrylate and a side chain consisting of a carbon-carbon multiple bond-containing group.

Abstract: An object of the present invention is to provide means for treating post-traumatic stress disorder or a blast-induced traumatic brain injury-protective agent. The present invention provides a pharmaceutical composition containing hydrogen as an active ingredient, used for treating post-traumatic stress disorder or protecting against blast-induced traumatic brain injury.

Abstract: An anesthesia device configured to measure the hydrogen concentration in an anesthesia gas containing a hydrogen gas includes: an anesthesia gas preparation circuit configured to generate anesthesia gas by mixing an air or an oxygen mixture air with a vaporized anesthetic; a closed circuit-type or semi-closed circuit-type respiratory circuit including a gas circulation passage configured to circulate the hydrogen-containing anesthesia gas containing the hydrogen gas and the vaporized anesthetic; and a hydrogen concentration measurement circuit configured to measure the hydrogen concentration in the hydrogen-containing anesthesia gas in the gas circulation passage, wherein the hydrogen concentration measurement circuit includes: an anesthetic removing member having a removability of the vaporized anesthetic in the hydrogen-containing anesthesia gas; and a hydrogen concentration measuring instrument provided on the secondary side of the anesthetic removing member.

Abstract: An anesthesia device configured to measure the hydrogen concentration in an anesthesia gas containing a hydrogen gas includes: an anesthesia gas preparation circuit configured to generate anesthesia gas by mixing an air or an oxygen mixture air with a vaporized anesthetic; a closed circuit-type or semi-closed circuit-type respiratory circuit including a gas circulation passage configured to circulate the hydrogen-containing anesthesia gas containing the hydrogen gas and the vaporized anesthetic; and a hydrogen concentration measurement circuit configured to measure the hydrogen concentration in the hydrogen-containing anesthesia gas in the gas circulation passage, wherein the hydrogen concentration measurement circuit includes: an anesthetic removing member having a removability of the vaporized anesthetic in the hydrogen-containing anesthesia gas; and a hydrogen concentration measuring instrument provided on the secondary side of the anesthetic removing member.

Abstract: An object of the present invention is to provide a medicine for general anesthesia which can prevent and/or alleviate an anesthetic-induced neurological deficit in the brain (preferably in the developing brain). The present invention relates to a medicine which comprises a combination of a general anesthetic and hydrogen and can prevent and/or alleviate an anesthetic-induced neurological deficit in the brain (preferably in the developing brain).

Abstract: A main chain type liquid crystalline polyester comprises at least two units selected from aromatic diol units, aromtic dicarboxylic acid units, and aromatic hydroxycarboxylic acid units as essential units and a structural unit containing a cationically polymerizable group selected from the group consisting of vinyloxy groups, epoxy groups, and oxetany groups in at least one of the terminal ends of the main chain.

Abstract: Provided is a main chain type liquid crystal polyester which comprises at least two units selected from an aromatic diol unit, an aromatic dicarboxylic acid unit, and an aromatic hydroxycarboxylic acid unit as essential units and a structural unit having a cationically polymerizable unit in at least one of the terminal ends. The main chain type liquid crystalline polyester, when used as an optical material, is excellent in the capability of retaining a liquid crystal orientation having been aligned and fixed under practical service conditions and exhibits an excellent mechanical strength.

Abstract: A complex diffraction device, which is excellent in designability, easy in setting the diffraction angle, adaptable to size increase, and easy to handle by adding a diffraction function resulting from an uneven pattern to the diffraction device comprising a liquid crystalline layer where the helical orientation of the smectic liquid crystal phase having a helical structure is maintained.

Abstract: A complex diffraction device, which is excellent in designability, easy in setting the diffraction angle, adaptable to size increase, and easy to handle by adding a diffraction function resulting from an uneven pattern to the diffraction device comprising a liquid crystalline layer where the helical orientation of the smectic liquid crystal phase having a helical structure is maintained.

Abstract: A film for optical elements is formed by a liquid crystalline composition comprising the following components (a) and (b): (a) a liquid crystalline polymer which exhibits an optically positive uniaxial property; and (b) a polycyclic compound having a molecular weight of not more than 1,000 and wherein a plurality of alicyclic rings and/or aromatic rings are connected together through a linkage chain of 0 to 4 main-chain carbon atoms bonded to different ring carbon atoms, with hydrocarbon groups each having 1 to 20 carbon atoms being bonded respectively to both end rings through a linkage chain of 0 to 4 main-chain carbon atoms, an orientation form formed in the state of liquid crystal of said liquid crystalline composition being fixed.

Abstract: An object of the present invention is to provide an optical fiber strain measuring apparatus which can perform precise measurement without causing any fluctuation in signal level.

Abstract: A compensating film capable of compensating both twist structure based on a liquid crystal cell and refractive index anisotropy to diminish the visual angle dependence of a liquid crystal display is provided.The film is formed using a discotic liquid crystalline material and the orientation form of the discotic liquid crystal is a twisted orientation.

Abstract: An image forming apparatus for forming an image on a recording medium has an image forming system for forming an image on the recording medium, a second image forming system for forming an image on the recording medium based on an image forming method different from that for the first image forming system, a first recording medium transport passage for discharging the recording medium out of the apparatus after the recording medium has passed through the first and second image forming systems, a second recording medium transport passage for discharging the recording medium out of the apparatus without passing the recording medium through the second image forming system after the recording medium has passed through the first image forming system, and a third recording medium transport passage for discharging the recording medium out of the apparatus without passing the recording medium through the first image forming system after the recording medium has passed through the second image forming system.

Abstract: An atomic force microscope comprises a probe having a sharply-pointed tip end. The probe is supported on the free end portion of a cantilever and is close to the surface of a specimen. When an interatomic force is produced, the cantilever is deformed, and the probe is displaced. The displacement of the probe is detected by an optical system. A light beam emitted from a light source is collimated by a lens, and reflected by a polarized beam-splitter, and also by a half-mirror. Then, the light beam passes through a quarter wavelength plate and an objective lens, such that the light is converged on the cantilever. The reflected light beam from the cantilever returns along the same optical path and passes through the splitter. The light beam is divided into two light beams at the splitter. These two light beams are reflected by respective prisms and are then incident on respective photodetectors. These photodetectors detect the displacement of the probe.

Abstract: Disclosed is an apparatus for detecting abnormality in a secondary air supplier of an engine. The operational status of the engine is monitored by various sensors. When the engine is in a warmed-up state, an electronic control unit (ECU) disables the secondary air supplier to stop secondary air from being supplied to an exhaust manifold. When the engine is in such an operational status in which the secondary air should be supplied, the secondary air supplier is activated and a fuel supplying means is controlled in such a way that a suction air-fuel ratio is forcibly adjusted to a predetermined high value so as to set an exhaust air-fuel ratio low when the secondary air supplier functions properly and set the exhaust air-fuel ratio high when the secondary air supplier is abnormal. When the exhaust air-fuel ratio is detected to be high, the ECU judges the secondary air supplier as abnormal and executes necessary processing, such as outputting an abnormality judgment signal to an external warning device.

Abstract: A MOS integrated circuit including P-channel MOS transistors, particularly for C-MOS inverter, in which the P-channel MOS transistor (12) has P.sup.+ drain (34), P.sup.+ source (36) connected to a +VDD circuit (42) via P.sup.+ and N.sup.+ diffusion layers (36.sub.1, 36.sub.2) and isolation gate (38). The P.sup.+ layer is partly replaced by, i.e. parallel- and/or serial-connected to the N.sup.+ layer so that an effective source diffusion resistance (R.sub.S) or the conductive resistance (R.sub.0) is lowered.